Core Viewpoint - The Chinese cosmetics industry is undergoing a significant "ingredient revolution," with recombinant collagen emerging as a core force in reconstructing product value systems. The key question remains whether large molecular recombinant collagen can effectively penetrate the skin barrier to reach its target sites [3][4]. Group 1: Technological Breakthroughs - The "transdermal collagen" technology developed by Kemi, a brand under Furuida Bio Co., has been recognized as reaching an internationally leading level by the China Light Industry Federation [4][20]. - Kemi's technology has achieved a 27.5 times increase in transdermal efficiency, addressing the industry-wide challenge of large molecular penetration [6][10]. - The core issue of collagen efficacy lies in the dilemma of activity versus permeability, with traditional methods reducing molecular size at the cost of biological activity [7][11]. Group 2: Innovative Solutions - Kemi's solution involves a systematic technology called "transdermal collagen," which enhances the penetration ability of large molecular collagen through genetic engineering [8][11]. - The "transmembrane peptide" acts as a "biological engine," enabling large molecular collagen to actively penetrate cell membranes, thus overcoming traditional passive diffusion limitations [8][10]. - The "super glass collagen microsphere" technology ensures stable presence and sustained release of active collagen within the skin, significantly improving penetration rates [10][11]. Group 3: Market Validation - Kemi's flagship product, the "Kemi Recombinant Collagen Anti-Wrinkle Essence," combines the two proprietary delivery technologies, resulting in measurable skincare effects [12][14]. - In just eight months, the transdermal collagen essence achieved sales exceeding 23 million units, topping various e-commerce beauty charts [14][15]. - The brand's marketing strategy focuses on building trust through deep communication and collaboration with authoritative media, enhancing consumer perception of its technological innovations [15][16]. Group 4: Industry Impact and Standards - Kemi has transitioned from a "dark horse" to a "definer" in the industry, actively participating in the formulation of industry standards, including the first group standard for measuring the penetration efficacy of recombinant collagen [20][23]. - The establishment of these standards marks a shift from vague marketing claims to quantifiable scientific parameters, promoting a new phase of verifiable efficacy in the industry [24][25]. - Kemi's approach signifies a broader industry shift from marketing-driven strategies to technology-driven value creation, setting a benchmark for future developments in the cosmetics sector [25].

皮肤衰老的本质，是胶原纤维网的崩塌。但如何让外源性胶原穿透角质层这座"铜墙铁壁"，始 终是行业难题。消费者一边为"胶原流失"焦虑，一边质疑涂抹产品的实际功效——分子量超过 5 0 0道尔顿的胶原蛋白真能渗透吗？活性成分会被皮肤"拒之门外"吗？ 2 0 2 5 年 4 月 ， 福 瑞 达 生 物 股 份 旗 下 珂 谧 在 济 南 召 开 的 " 2 0 2 5 重 组 胶 原 蛋 白 技 术 发 布 会 暨 珂 谧 Ke y C穿膜胶原新品首发式"上，给出了一个颠覆性答案。 这场以"穿膜胶原"为核心的技术革命，不仅将胶原透皮效率提升2 7 . 5倍，更让中国美妆科技首 次 站 上 全 球 抗 衰 技 术 竞 争 的 制 高 点 。 这 场 突 破 背 后 ， 是 科 研 逻 辑 的 颠 覆 ， 还 是 产 业 格 局 的 重 构？ 皮肤角质层的屏障功能，曾被视作大分子胶原的"天堑"。 传统透皮法则认为，分子量超过5 0 0道尔顿的成分难以穿透角质层。但福瑞达生物股份科研团 队选择了一条反直觉的技术路径—— 不是缩小分子量，而是给胶原装上"穿膜引擎" 。这场看 似违背常识的技术突围，实则是一场从基因设计到分子工 ...